CovidFranceV1, Main, Exploration, bibRecord, 001170

Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?

Identifieur interne : 001170 ( Main/Exploration ); précédent : 001169; suivant : 001171

Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?

Auteurs : Martin Cour [France] ; Michel Ovize [France] ; Laurent Argaud [France]

Source :

Critical care (London, England) [ 1466-609X ] ; 2020.

RBID : pubmed:32487139

Descripteurs français

KwdFr :
- Ciclosporine (usage thérapeutique), Humains (MeSH), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (épidémiologie), Insuffisance respiratoire (traitement médicamenteux), Insuffisance respiratoire (épidémiologie), Maladie aigüe (MeSH), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (épidémiologie), Résultat thérapeutique (MeSH).
MESH :
- traitement médicamenteux : Infections à coronavirus, Insuffisance respiratoire, Pneumopathie virale.
- usage thérapeutique : Ciclosporine.
- épidémiologie : Infections à coronavirus, Insuffisance respiratoire, Pneumopathie virale.
- Humains, Maladie aigüe, Pandémies, Résultat thérapeutique.

English descriptors

KwdEn :
- Acute Disease (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Cyclosporine (therapeutic use), Humans (MeSH), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Respiratory Insufficiency (drug therapy), Respiratory Insufficiency (epidemiology), Treatment Outcome (MeSH).
MESH :
- chemical , therapeutic use : Cyclosporine.
- drug therapy : Coronavirus Infections, Pneumonia, Viral, Respiratory Insufficiency.
- epidemiology : Coronavirus Infections, Pneumonia, Viral, Respiratory Insufficiency.
- Acute Disease, Humans, Pandemics, Treatment Outcome.

DOI: 10.1186/s13054-020-03014-1
PubMed: 32487139
PubMed Central: PMC7265662

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000F93
to stream Main, to step Curation: 000F93

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?</title>
<author><name sortKey="Cour, Martin" sort="Cour, Martin" uniqKey="Cour M" first="Martin" last="Cour">Martin Cour</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ovize, Michel" sort="Ovize, Michel" uniqKey="Ovize M" first="Michel" last="Ovize">Michel Ovize</name>
<affiliation wicri:level="3"><nlm:affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Hospices Civils de Lyon, Centre d'Investigation Clinique de Lyon, Université de Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospices Civils de Lyon, Centre d'Investigation Clinique de Lyon, Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Argaud, Laurent" sort="Argaud, Laurent" uniqKey="Argaud L" first="Laurent" last="Argaud">Laurent Argaud</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03, France. laurent.argaud@chu-lyon.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France. laurent.argaud@chu-lyon.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32487139</idno>
<idno type="pmid">32487139</idno>
<idno type="doi">10.1186/s13054-020-03014-1</idno>
<idno type="pmc">PMC7265662</idno>
<idno type="wicri:Area/Main/Corpus">000F93</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F93</idno>
<idno type="wicri:Area/Main/Curation">000F93</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000F93</idno>
<idno type="wicri:Area/Main/Exploration">000F93</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?</title>
<author><name sortKey="Cour, Martin" sort="Cour, Martin" uniqKey="Cour M" first="Martin" last="Cour">Martin Cour</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ovize, Michel" sort="Ovize, Michel" uniqKey="Ovize M" first="Michel" last="Ovize">Michel Ovize</name>
<affiliation wicri:level="3"><nlm:affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Hospices Civils de Lyon, Centre d'Investigation Clinique de Lyon, Université de Lyon, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospices Civils de Lyon, Centre d'Investigation Clinique de Lyon, Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Argaud, Laurent" sort="Argaud, Laurent" uniqKey="Argaud L" first="Laurent" last="Argaud">Laurent Argaud</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03, France. laurent.argaud@chu-lyon.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03</wicri:regionArea>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France. laurent.argaud@chu-lyon.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Critical care (London, England)</title>
<idno type="eISSN">1466-609X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Cyclosporine (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Respiratory Insufficiency (drug therapy)</term>
<term>Respiratory Insufficiency (epidemiology)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Ciclosporine (usage thérapeutique)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Insuffisance respiratoire (traitement médicamenteux)</term>
<term>Insuffisance respiratoire (épidémiologie)</term>
<term>Maladie aigüe (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cyclosporine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Insuffisance respiratoire</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Ciclosporine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Insuffisance respiratoire</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Maladie aigüe</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32487139</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>06</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>Critical care (London, England)</Title>
<ISOAbbreviation>Crit Care</ISOAbbreviation>
</Journal>
<ArticleTitle>Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?</ArticleTitle>
<Pagination><MedlinePgn>276</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-020-03014-1</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cour</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ovize</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Hospices Civils de Lyon, Centre d'Investigation Clinique de Lyon, Université de Lyon, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Argaud</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">0000-0002-4565-2454</Identifier>
<AffiliationInfo><Affiliation>Hospices Civils de Lyon, Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, 5, place d'Arsonval, 69437, Lyon Cedex 03, France. laurent.argaud@chu-lyon.fr.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>INSERM UMR1060 (CarMeN), Université de Lyon, Lyon, France. laurent.argaud@chu-lyon.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Crit Care</MedlineTA>
<NlmUniqueID>9801902</NlmUniqueID>
<ISSNLinking>1364-8535</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>83HN0GTJ6D</RegistryNumber>
<NameOfSubstance UI="D016572">Cyclosporine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016572" MajorTopicYN="N">Cyclosporine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>6</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32487139</ArticleId>
<ArticleId IdType="doi">10.1186/s13054-020-03014-1</ArticleId>
<ArticleId IdType="pii">10.1186/s13054-020-03014-1</ArticleId>
<ArticleId IdType="pmc">PMC7265662</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>N Engl J Med. 2006 Jan 12;354(2):141-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16407509</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anesthesiology. 2014 Aug;121(2):232-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25050491</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2018 Sep;522:46-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30014857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochim Biophys Acta. 2015 Dec;1852(12):2563-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26385159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacology. 2017;100(1-2):83-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28501872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2016 Aug 1;1(5):557-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27433815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 May;8(5):506-517</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32272080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2011 Oct;7(10):e1002331</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22046132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Pharmacol. 2019 May;163:472-480</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30880061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Pharmacol. 2012 Mar;165(5):1235-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21955136</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Resuscitation. 2019 May;138:129-131</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30878374</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Intensive Care Med. 2020 Apr 21;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32318777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ERJ Open Res. 2019 Oct 30;5(4):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31687370</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Apr 13;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2015 Sep 10;373(11):1021-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26321103</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Lyon</li>
</settlement>
</list>
<tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Cour, Martin" sort="Cour, Martin" uniqKey="Cour M" first="Martin" last="Cour">Martin Cour</name>
</region>
<name sortKey="Argaud, Laurent" sort="Argaud, Laurent" uniqKey="Argaud L" first="Laurent" last="Argaud">Laurent Argaud</name>
<name sortKey="Argaud, Laurent" sort="Argaud, Laurent" uniqKey="Argaud L" first="Laurent" last="Argaud">Laurent Argaud</name>
<name sortKey="Cour, Martin" sort="Cour, Martin" uniqKey="Cour M" first="Martin" last="Cour">Martin Cour</name>
<name sortKey="Ovize, Michel" sort="Ovize, Michel" uniqKey="Ovize M" first="Michel" last="Ovize">Michel Ovize</name>
<name sortKey="Ovize, Michel" sort="Ovize, Michel" uniqKey="Ovize M" first="Michel" last="Ovize">Michel Ovize</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001170 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001170 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32487139
   |texte=   Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32487139" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?

Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki